BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1106 related articles for article (PubMed ID: 7850935)

  • 1. Comparison of low-dose dobutamine-gradient-echo magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability.
    Baer FM; Voth E; Schneider CA; Theissen P; Schicha H; Sechtem U
    Circulation; 1995 Feb; 91(4):1006-15. PubMed ID: 7850935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. F-18-FDG uptake is a reliable predictory of functional recovery of akinetic but viable infarct regions as defined by magnetic resonance imaging before and after revascularization.
    Schmidt M; Voth E; Schneider CA; Theissen P; Wagner R; Baer FM; Schicha H
    Magn Reson Imaging; 2004 Feb; 22(2):229-36. PubMed ID: 15010115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of dobutamine transesophageal echocardiography and dobutamine magnetic resonance imaging for detection of residual myocardial viability.
    Baer FM; Voth E; LaRosée K; Schneider CA; Theissen P; Deutsch HJ; Schicha H; Erdmann E; Sechtem U
    Am J Cardiol; 1996 Aug; 78(4):415-9. PubMed ID: 8752185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of low dose dobutamine transesophageal echocardiography and fluorine-18 fluorodeoxyglucose positron emission tomography for recovery of regional left ventricular function after successful revascularization.
    Baer FM; Voth E; Deutsch HJ; Schneider CA; Horst M; de Vivie ER; Schicha H; Erdmann E; Sechtem U
    J Am Coll Cardiol; 1996 Jul; 28(1):60-9. PubMed ID: 8752795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of viable myocardium by dobutamine transesophageal echocardiography and comparison with fluorine-18 fluorodeoxyglucose positron emission tomography.
    Baer FM; Voth E; Deutsch HJ; Schneider CA; Schicha H; Sechtem U
    J Am Coll Cardiol; 1994 Aug; 24(2):343-53. PubMed ID: 8034866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization.
    Baer FM; Theissen P; Schneider CA; Voth E; Sechtem U; Schicha H; Erdmann E
    J Am Coll Cardiol; 1998 Apr; 31(5):1040-8. PubMed ID: 9562005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional 99mTc-methoxyisobutyl-isonitrile-uptake at rest in patients with myocardial infarcts: comparison with morphological and functional parameters obtained from gradient-echo magnetic resonance imaging.
    Baer FM; Smolarz K; Theissen P; Voth E; Schicha H; Sechtem U
    Eur Heart J; 1994 Jan; 15(1):97-107. PubMed ID: 8174590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(16):1-80. PubMed ID: 23074393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional left ventricular wall thickening. Relation to regional uptake of 18fluorodeoxyglucose and 201Tl in patients with chronic coronary artery disease and left ventricular dysfunction.
    Perrone-Filardi P; Bacharach SL; Dilsizian V; Maurea S; Frank JA; Bonow RO
    Circulation; 1992 Oct; 86(4):1125-37. PubMed ID: 1394920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(16):1-167. PubMed ID: 23074467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial viability: fluorine-18-deoxyglucose positron emission tomography in prediction of wall motion recovery after revascularization.
    Knuuti MJ; Saraste M; Nuutila P; Härkönen R; Wegelius U; Haapanen A; Bergman J; Haaparanta M; Savunen T; Voipio-Pulkki LM
    Am Heart J; 1994 Apr; 127(4 Pt 1):785-96. PubMed ID: 8154416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose dobutamine stress gated SPET for identification of viable myocardium: comparison with stress-rest perfusion SPET and PET.
    Yoshinaga K; Katoh C; Noriyasu K; Yamada S; Ito Y; Kuge Y; Kawai Y; Kohya T; Kitabatake A; Tamaki N
    Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):882-90. PubMed ID: 12111128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dobutamine magnetic resonance imaging predicts contractile reserve of chronically dysfunctional myocardium: comparison with was fluorine-18 fluorodeoxyglucose positron emission tomography.
    Zhao S; Liu S; Janier M; Croisille P; Roux JP; Revel D
    Chin Med Sci J; 2000 Mar; 15(1):29-34. PubMed ID: 12899396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose dobutamine electrocardiograph-gated myocardial SPECT for identifying viable myocardium: comparison with dobutamine stress echocardiography and PET.
    Yoshinaga K; Morita K; Yamada S; Komuro K; Katoh C; Ito Y; Kuge Y; Kohya T; Kitabatake A; Tamaki N
    J Nucl Med; 2001 Jun; 42(6):838-44. PubMed ID: 11390545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance imaging (MRI) for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(15):1-45. PubMed ID: 23074392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation between contractile reserve and positron emission tomographic patterns of perfusion and glucose utilization in chronic ischemic left ventricular dysfunction: implications for identification of myocardial viability.
    Mélon PG; de Landsheere CM; Degueldre C; Peters JL; Kulbertus HE; Piérard LA
    J Am Coll Cardiol; 1997 Dec; 30(7):1651-9. PubMed ID: 9385890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic evidence of viable myocardium in regions with reduced wall thickness and absent wall thickening in patients with chronic ischemic left ventricular dysfunction.
    Perrone-Filardi P; Bacharach SL; Dilsizian V; Maurea S; Marin-Neto JA; Arrighi JA; Frank JA; Bonow RO
    J Am Coll Cardiol; 1992 Jul; 20(1):161-8. PubMed ID: 1607518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gradient-echo magnetic resonance imaging during incremental dobutamine infusion for the localization of coronary artery stenoses.
    Baer FM; Voth E; Theissen P; Schicha H; Sechtem U
    Eur Heart J; 1994 Feb; 15(2):218-25. PubMed ID: 8005123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of left ventricular functional recovery by dobutamine echocardiography, F-18 deoxyglucose or 99mTc sestamibi nuclear imaging in patients with chronic myocardial infarction.
    Lund GK; Freyhoff J; Schwaiger M; Lübeck M; Lund CH; Buchert R; Sheehan FH; Meinertz T; Nienaber CA
    Cardiology; 2002; 98(4):202-9. PubMed ID: 12566650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dobutamine-stress electrocardiographically gated positron emission tomography for detection of viable but dysfunctional myocardium.
    Yamagishi H; Akioka K; Hirata K; Sakanoue Y; Toda I; Yoshiyama M; Teragaki M; Takeuchi K; Yoshikawa J; Ochi H
    J Nucl Cardiol; 1999; 6(6):626-32. PubMed ID: 10608590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.